[go: up one dir, main page]

IT8322629A0 - Derivati di benzammidi. - Google Patents

Derivati di benzammidi.

Info

Publication number
IT8322629A0
IT8322629A0 IT8322629A IT2262983A IT8322629A0 IT 8322629 A0 IT8322629 A0 IT 8322629A0 IT 8322629 A IT8322629 A IT 8322629A IT 2262983 A IT2262983 A IT 2262983A IT 8322629 A0 IT8322629 A0 IT 8322629A0
Authority
IT
Italy
Prior art keywords
benzamidies
derivatives
Prior art date
Application number
IT8322629A
Other languages
English (en)
Other versions
IT1169775B (it
Inventor
Michael John Ashton
David Charles Cook
James Daniels
Howard Lovelles
Jeremy David Pratt
Bernard Thomas Bull
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of IT8322629A0 publication Critical patent/IT8322629A0/it
Application granted granted Critical
Publication of IT1169775B publication Critical patent/IT1169775B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT22629/83A 1982-08-24 1983-08-24 Derivati di benzammidi IT1169775B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24

Publications (2)

Publication Number Publication Date
IT8322629A0 true IT8322629A0 (it) 1983-08-24
IT1169775B IT1169775B (it) 1987-06-03

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22629/83A IT1169775B (it) 1982-08-24 1983-08-24 Derivati di benzammidi

Country Status (23)

Country Link
US (1) US4507315A (it)
JP (1) JPS5955873A (it)
KR (1) KR840005717A (it)
AT (1) ATA301083A (it)
AU (1) AU1818083A (it)
BE (1) BE897580A (it)
CA (1) CA1195993A (it)
CS (1) CS240973B2 (it)
DE (1) DE3330403A1 (it)
DK (1) DK386783A (it)
ES (2) ES525099A0 (it)
FI (1) FI832989A7 (it)
FR (1) FR2532310B1 (it)
GB (1) GB2126225B (it)
GR (1) GR78673B (it)
IL (1) IL69544A0 (it)
IT (1) IT1169775B (it)
LU (1) LU84974A1 (it)
NL (1) NL8302947A (it)
NO (1) NO833024L (it)
PT (1) PT77219B (it)
SE (1) SE8304545L (it)
ZA (1) ZA836191B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
EP1196385A1 (en) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
EA200700717A1 (ru) 2004-09-24 2007-10-26 Янссен Фармацевтика Н.В. Сульфонамиды

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
ES8502691A1 (es) 1985-01-16
ES525099A0 (es) 1985-01-16
IT1169775B (it) 1987-06-03
ZA836191B (en) 1984-04-25
SE8304545L (sv) 1984-02-25
FI832989A0 (fi) 1983-08-22
GR78673B (it) 1984-09-27
PT77219B (fr) 1986-02-04
DK386783A (da) 1984-02-25
US4507315A (en) 1985-03-26
FI832989A7 (fi) 1984-02-25
CA1195993A (en) 1985-10-29
NL8302947A (nl) 1984-03-16
CS612483A2 (en) 1985-06-13
ES528012A0 (es) 1985-06-16
ATA301083A (de) 1985-11-15
AU1818083A (en) 1984-03-01
PT77219A (fr) 1983-09-01
ES8505935A1 (es) 1985-06-16
GB2126225B (en) 1985-10-09
DE3330403A1 (de) 1984-03-01
IL69544A0 (en) 1983-11-30
KR840005717A (ko) 1984-11-16
LU84974A1 (fr) 1984-03-23
BE897580A (fr) 1984-02-23
FR2532310B1 (fr) 1986-01-10
NO833024L (no) 1984-02-24
CS240973B2 (en) 1986-03-13
FR2532310A1 (fr) 1984-03-02
SE8304545D0 (sv) 1983-08-22
JPS5955873A (ja) 1984-03-31
GB2126225A (en) 1984-03-21
GB8322539D0 (en) 1983-09-21
DK386783D0 (da) 1983-08-23

Similar Documents

Publication Publication Date Title
IT7919908A0 (it) Derivati di alchilendiamine.
IT8022265A0 (it) Derivati di alchil-chetoesopiranosidi.
IT8521865A0 (it) Derivati di etilendiamminomonoammidi.
DE3371513D1 (de) Propynylaminoisoxazole derivatives
DE3372768D1 (de) 1-sulfo-2-oxoazetidine derivatives
IT1210480B (it) Derivati ergolinici.
IT1205272B (it) Derivati ergolinici
IT8125198A0 (it) Derivati salicilici di n-acetilcisteina.
IT1203608B (it) Derivati di prolina
DE3369990D1 (de) Methylflavone derivatives
IT1215630B (it) Derivati di ergolina.
DE3364323D1 (de) Phenoxypropanolamine derivatives
IT8322629A0 (it) Derivati di benzammidi.
IT8322230A0 (it) Carbapenem-derivati fluoroalchilati.
IT8321040A0 (it) Derivati della aleteina.
IT8419778A0 (it) Derivati di benzammidi.
IT1210473B (it) Procedimento per la preparazione di derivati ergolinici.
IT8119187A0 (it) Derivati di rifamicina.
IT8026229A0 (it) Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnani ci.
IT7922447A0 (it) Derivati di n-ciano-azometini.
ATE34749T1 (de) Acridanon-derivate.
IT1136673B (it) Derivati di 3-aril- e 3-eterociclil -2,3-diidro-1,4-benzos sazina
IT8123213A0 (it) Derivati tetraidrochinolici
IT1178768B (it) Derivati di pirazolo piridina
IT1183330B (it) Derivati di fenilpropargilammine